Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Crohn Disease | 19 | 2024 | 2255 | 2.100 |
Why?
|
| Colitis, Ulcerative | 13 | 2016 | 1911 | 1.240 |
Why?
|
| Inflammatory Bowel Diseases | 14 | 2022 | 2404 | 1.070 |
Why?
|
| Gastroesophageal Reflux | 7 | 2016 | 813 | 0.620 |
Why?
|
| Actigraphy | 1 | 2019 | 513 | 0.500 |
Why?
|
| Gastrointestinal Agents | 2 | 2016 | 506 | 0.490 |
Why?
|
| Esophageal pH Monitoring | 7 | 2016 | 200 | 0.470 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2016 | 1793 | 0.440 |
Why?
|
| Mesalamine | 3 | 2008 | 136 | 0.420 |
Why?
|
| Biological Products | 2 | 2022 | 903 | 0.400 |
Why?
|
| Gene Expression Profiling | 3 | 2015 | 9356 | 0.400 |
Why?
|
| Azathioprine | 3 | 2008 | 352 | 0.390 |
Why?
|
| Colonoscopy | 7 | 2019 | 1377 | 0.370 |
Why?
|
| Severity of Illness Index | 8 | 2024 | 15680 | 0.310 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2007 | 77 | 0.300 |
Why?
|
| Lung Transplantation | 5 | 2017 | 1279 | 0.290 |
Why?
|
| Gastrointestinal Motility | 1 | 2008 | 233 | 0.280 |
Why?
|
| Diarrhea | 2 | 2011 | 1336 | 0.270 |
Why?
|
| Interleukin-23 | 1 | 2006 | 192 | 0.250 |
Why?
|
| Colorectal Neoplasms | 4 | 2015 | 6792 | 0.240 |
Why?
|
| Triazines | 1 | 2006 | 310 | 0.240 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2024 | 93 | 0.230 |
Why?
|
| Interleukin-12 | 1 | 2006 | 577 | 0.230 |
Why?
|
| RNA | 1 | 2013 | 2700 | 0.220 |
Why?
|
| Fertilization in Vitro | 3 | 2016 | 1277 | 0.220 |
Why?
|
| Morpholines | 1 | 2006 | 583 | 0.210 |
Why?
|
| Esophagus | 1 | 2008 | 1020 | 0.210 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2003 | 167 | 0.200 |
Why?
|
| Leukocytes | 1 | 2010 | 2028 | 0.200 |
Why?
|
| Remission Induction | 5 | 2016 | 2368 | 0.190 |
Why?
|
| Cross Infection | 1 | 2010 | 1426 | 0.190 |
Why?
|
| Folic Acid | 1 | 2007 | 1299 | 0.180 |
Why?
|
| Gastrostomy | 1 | 2003 | 316 | 0.180 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 2 | 2016 | 490 | 0.180 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2024 | 858 | 0.180 |
Why?
|
| RNA, Messenger | 1 | 2015 | 12739 | 0.170 |
Why?
|
| Infertility | 3 | 2016 | 652 | 0.170 |
Why?
|
| Length of Stay | 3 | 2019 | 6372 | 0.170 |
Why?
|
| Patient Readmission | 3 | 2019 | 3288 | 0.170 |
Why?
|
| Colitis | 2 | 2004 | 1216 | 0.160 |
Why?
|
| Feces | 1 | 2024 | 1438 | 0.150 |
Why?
|
| Enteral Nutrition | 1 | 2003 | 777 | 0.140 |
Why?
|
| Heartburn | 1 | 2016 | 67 | 0.130 |
Why?
|
| Intestinal Polyps | 1 | 2015 | 104 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4571 | 0.130 |
Why?
|
| Proton Pump Inhibitors | 2 | 2017 | 544 | 0.120 |
Why?
|
| Middle Aged | 29 | 2024 | 217039 | 0.120 |
Why?
|
| Esophageal Stenosis | 1 | 2016 | 195 | 0.120 |
Why?
|
| Electric Impedance | 5 | 2016 | 740 | 0.120 |
Why?
|
| Adult | 27 | 2024 | 216927 | 0.120 |
Why?
|
| Immunosuppressive Agents | 3 | 2016 | 4067 | 0.110 |
Why?
|
| Adenoma | 2 | 2015 | 2141 | 0.110 |
Why?
|
| Colonic Pouches | 1 | 2014 | 122 | 0.110 |
Why?
|
| Case-Control Studies | 5 | 2016 | 21851 | 0.110 |
Why?
|
| Patient Compliance | 2 | 2014 | 2679 | 0.110 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2016 | 182 | 0.110 |
Why?
|
| Graft Rejection | 2 | 2017 | 4219 | 0.110 |
Why?
|
| Humans | 44 | 2024 | 752411 | 0.110 |
Why?
|
| Aged | 20 | 2019 | 166585 | 0.110 |
Why?
|
| Intestinal Neoplasms | 1 | 2015 | 310 | 0.110 |
Why?
|
| Male | 30 | 2024 | 354908 | 0.100 |
Why?
|
| Female | 33 | 2024 | 386085 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 11884 | 0.100 |
Why?
|
| Continuity of Patient Care | 1 | 2019 | 1050 | 0.100 |
Why?
|
| Sensitivity and Specificity | 3 | 2016 | 14588 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 2 | 2008 | 7295 | 0.100 |
Why?
|
| Young Adult | 12 | 2024 | 57632 | 0.100 |
Why?
|
| Receptors, Interleukin-1 Type II | 1 | 2011 | 11 | 0.100 |
Why?
|
| Aminohydrolases | 1 | 2011 | 18 | 0.100 |
Why?
|
| Oxo-Acid-Lyases | 1 | 2011 | 22 | 0.090 |
Why?
|
| alpha Karyopherins | 1 | 2011 | 41 | 0.090 |
Why?
|
| Eosinophils | 1 | 2016 | 945 | 0.090 |
Why?
|
| Esophagoscopy | 2 | 2016 | 391 | 0.090 |
Why?
|
| Colonic Neoplasms | 2 | 2014 | 2500 | 0.090 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2011 | 88 | 0.090 |
Why?
|
| Lung Injury | 1 | 2015 | 423 | 0.090 |
Why?
|
| Self Efficacy | 1 | 2014 | 623 | 0.090 |
Why?
|
| Colonic Polyps | 1 | 2015 | 547 | 0.090 |
Why?
|
| Deglutition Disorders | 1 | 2016 | 617 | 0.090 |
Why?
|
| Prognosis | 5 | 2019 | 29337 | 0.090 |
Why?
|
| Logistic Models | 5 | 2019 | 13277 | 0.090 |
Why?
|
| Infertility, Female | 1 | 2016 | 755 | 0.090 |
Why?
|
| Treatment Outcome | 11 | 2016 | 64250 | 0.090 |
Why?
|
| Abdominal Pain | 1 | 2016 | 1060 | 0.080 |
Why?
|
| Diagnosis, Differential | 4 | 2016 | 12901 | 0.080 |
Why?
|
| Pennsylvania | 1 | 2010 | 610 | 0.080 |
Why?
|
| Population Surveillance | 2 | 2016 | 2598 | 0.080 |
Why?
|
| Precancerous Conditions | 1 | 2015 | 969 | 0.080 |
Why?
|
| Esophagitis, Peptic | 1 | 2008 | 77 | 0.080 |
Why?
|
| Cholagogues and Choleretics | 1 | 2007 | 35 | 0.080 |
Why?
|
| Comorbidity | 2 | 2019 | 10475 | 0.070 |
Why?
|
| Tomography, Emission-Computed | 1 | 2010 | 1115 | 0.070 |
Why?
|
| Retrospective Studies | 16 | 2022 | 79133 | 0.070 |
Why?
|
| ROC Curve | 3 | 2024 | 3532 | 0.070 |
Why?
|
| Prospective Studies | 6 | 2024 | 53809 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2007 | 2266 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2016 | 2509 | 0.070 |
Why?
|
| Cross-Sectional Studies | 6 | 2019 | 25539 | 0.070 |
Why?
|
| Thioguanine | 1 | 2006 | 44 | 0.070 |
Why?
|
| Lung Diseases | 1 | 2016 | 1899 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6479 | 0.070 |
Why?
|
| Paraneoplastic Endocrine Syndromes | 1 | 1985 | 29 | 0.070 |
Why?
|
| Hydrazones | 1 | 2006 | 103 | 0.070 |
Why?
|
| Cyclosporine | 1 | 2008 | 752 | 0.070 |
Why?
|
| Respiratory Insufficiency | 1 | 2014 | 1209 | 0.070 |
Why?
|
| Vitamin B Complex | 1 | 2007 | 293 | 0.060 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1985 | 179 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 1344 | 0.060 |
Why?
|
| Patient Selection | 1 | 2016 | 4239 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2015 | 1867 | 0.060 |
Why?
|
| Receptors, Immunologic | 1 | 2011 | 1424 | 0.060 |
Why?
|
| Pouchitis | 1 | 2004 | 63 | 0.060 |
Why?
|
| Opioid-Related Disorders | 1 | 2018 | 2107 | 0.060 |
Why?
|
| Pheochromocytoma | 1 | 1985 | 326 | 0.060 |
Why?
|
| Cohort Studies | 8 | 2019 | 40980 | 0.050 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 39077 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3600 | 0.050 |
Why?
|
| Algorithms | 1 | 2003 | 13897 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2010 | 1993 | 0.050 |
Why?
|
| Methotrexate | 1 | 2008 | 1703 | 0.050 |
Why?
|
| Ileum | 1 | 2024 | 557 | 0.050 |
Why?
|
| Live Birth | 2 | 2016 | 505 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2010 | 2652 | 0.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 3146 | 0.050 |
Why?
|
| Health Services for the Aged | 1 | 2003 | 255 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2011 | 3908 | 0.040 |
Why?
|
| Clinical Trials as Topic | 2 | 2006 | 7996 | 0.040 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1985 | 732 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 3435 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 3166 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 11063 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2006 | 4002 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 6304 | 0.040 |
Why?
|
| Florida | 1 | 2019 | 419 | 0.040 |
Why?
|
| Ethics, Medical | 1 | 2003 | 787 | 0.040 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 58299 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 35932 | 0.040 |
Why?
|
| New York | 1 | 2019 | 873 | 0.030 |
Why?
|
| Health Care Surveys | 2 | 2014 | 2427 | 0.030 |
Why?
|
| Colon | 1 | 2004 | 1780 | 0.030 |
Why?
|
| Adolescent | 4 | 2019 | 86766 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 19901 | 0.030 |
Why?
|
| Retreatment | 1 | 2016 | 600 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2010 | 6413 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2006 | 2979 | 0.030 |
Why?
|
| Motivation | 2 | 2014 | 1976 | 0.030 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2016 | 728 | 0.030 |
Why?
|
| Physicians | 1 | 2011 | 4551 | 0.030 |
Why?
|
| Medically Uninsured | 1 | 2019 | 839 | 0.030 |
Why?
|
| Risk Factors | 5 | 2019 | 73425 | 0.030 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2014 | 190 | 0.030 |
Why?
|
| Self Report | 2 | 2014 | 3647 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 2003 | 1624 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2014 | 549 | 0.030 |
Why?
|
| Mood Disorders | 1 | 2019 | 1109 | 0.030 |
Why?
|
| Neoplasms | 2 | 2016 | 21806 | 0.030 |
Why?
|
| Cell Count | 1 | 2016 | 1832 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2015 | 1154 | 0.020 |
Why?
|
| Pregnancy Rate | 1 | 2014 | 645 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 9101 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2015 | 1614 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2015 | 12455 | 0.020 |
Why?
|
| Age Factors | 2 | 2019 | 18298 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2010 | 572 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2015 | 2635 | 0.020 |
Why?
|
| Time Factors | 3 | 2016 | 39846 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 15143 | 0.020 |
Why?
|
| Pregnancy | 3 | 2016 | 29441 | 0.020 |
Why?
|
| Hospitalization | 2 | 2019 | 10629 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2010 | 955 | 0.020 |
Why?
|
| Antibodies | 1 | 2016 | 2412 | 0.020 |
Why?
|
| Capsule Endoscopy | 1 | 2007 | 96 | 0.020 |
Why?
|
| United States | 3 | 2019 | 71438 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2022 | 3798 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2015 | 1571 | 0.020 |
Why?
|
| Inflammation | 1 | 2006 | 10696 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2019 | 2490 | 0.020 |
Why?
|
| Health Services Accessibility | 2 | 2014 | 5282 | 0.020 |
Why?
|
| Medicaid | 1 | 2019 | 2793 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 12138 | 0.020 |
Why?
|
| Radiometry | 1 | 2010 | 816 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6501 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2019 | 5370 | 0.020 |
Why?
|
| Antibodies, Fungal | 1 | 2004 | 34 | 0.010 |
Why?
|
| Monitoring, Ambulatory | 1 | 2007 | 350 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 4341 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2015 | 3806 | 0.010 |
Why?
|
| Acute Disease | 1 | 2014 | 7212 | 0.010 |
Why?
|
| Biopsy | 1 | 2015 | 6743 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 14325 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2019 | 4320 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 7735 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1985 | 2560 | 0.010 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2004 | 282 | 0.010 |
Why?
|
| Intestines | 1 | 2010 | 1895 | 0.010 |
Why?
|
| Prevalence | 1 | 2018 | 15508 | 0.010 |
Why?
|
| Quality of Life | 1 | 2003 | 13154 | 0.010 |
Why?
|
| Medicare | 1 | 2019 | 6686 | 0.010 |
Why?
|
| Probiotics | 1 | 2004 | 365 | 0.010 |
Why?
|
| Angiography | 1 | 1985 | 1607 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13405 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 10196 | 0.010 |
Why?
|
| Research Design | 1 | 2015 | 6113 | 0.010 |
Why?
|
| Lung | 1 | 2017 | 9898 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2016 | 12796 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2010 | 3327 | 0.010 |
Why?
|
| Contrast Media | 1 | 2010 | 5285 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2010 | 8443 | 0.010 |
Why?
|
| Incidence | 1 | 2014 | 21157 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 2692 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1985 | 5919 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1985 | 20351 | 0.000 |
Why?
|
| Child | 1 | 2006 | 79004 | 0.000 |
Why?
|
Concepts
(213)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(34)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_